OssDesign's Catalyst nanosynthetic bone graft has been used in 1,000 patients, the medtech company said May 9.
In January, the comapny reached 500 cases with Catalyst, according to a news release. It's designed for spinal fusions and is made of a proprietary nanocrystalline structure that's resorbed and replaced over time.
The bone graft was launched in the U.S. in August 2021.